Collaboration initiates development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs) Biocytogen's RenLite® meets Acepodia's AD2C for precision oncology solutions ...
Year Track Record to Provide Award-Winning, Full-Service Hospitality Management Services to the Cruise Industry ...
Revolutionary iPSC line poised to accelerate development of groundbreaking treatments Pluristyx Announces Immediate Availability of GMP-Compliant PSXi013 iPSC Line for Advanced Therapy Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback